Target intelligence / Profile preview

Hepatocyte nuclear factor 4 gamma (HNF4G)

Target
HNF4G
Molecular classification
Nuclear receptor, Transcription factor
01

Overview

Hepatocyte nuclear factor 4 gamma (HNF4G) is a member of the nuclear receptor superfamily, functioning as a transcription factor. Encoded by the HNF4G gene, it is structurally similar to HNF4 alpha but has distinct tissue distribution—expressed in pancreas, kidney, small intestine, and testis, but largely absent in liver. HNF4G regulates gene expression involved in cell differentiation, especially in the intestinal epithelium and enterocyte lineage, and plays roles in metabolic and developmental pathways. Loss of HNF4G impairs enterocyte differentiation. It is implicated in cancer development, notably associated with poor prognosis due to its inhibition of caspase-dependent apoptosis, and is also linked to diabetes and metabolic diseases[1][2][3][4][5]. The protein is considered an orphan nuclear receptor, with some evidence for fatty acids as potential non-exchangeable endogenous co-factors rather than traditional ligand-binding[2].

Other names
Hepatocyte nuclear factor 4-gammaHNF-4-gammaNR2A2Nuclear receptor subfamily 2 group A member 2NR2A3
02

Mechanism of action

Modulation of gene transcription by binding to specific DNA cis-regulatory regions as a nuclear receptor/transcription factor[1][2][3]

03

Biological functions

Transcription regulationCell differentiationPositive regulation of transcription by RNA polymerase IIIntestinal epithelial cell differentiation
04

Disease associations

CancerMaturity-onset diabetes of the young (Type 1)HyperuricemiaOther metabolic and developmental disorders
05

Safety considerations

Oncogenic potential due to promotion of tumor cell growth and inhibition of apoptosis[5]potential metabolic dysregulation due to altered transcription of metabolic genes
06

Interacting drugs

Palmitic acid (low evidence, possibly endogenous fatty acids as co-factors rather than classical drug ligands)[3][2]
07

Biomarkers

Loss of enterocyte differentiationExpression levels in tumor prognosis, especially in relation to poor prognosis in tumors[1][5]

Beyond the preview

Go deeper on Hepatocyte nuclear factor 4 gamma (HNF4G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte nuclear factor 4 gamma (HNF4G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call